These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 6424257)
1. Acute renal failure following administration of ethylenediamine-tetraacetic acid (EDTA). Oliver LD; Mehta R; Sarles HE Tex Med; 1984 Feb; 80(2):40-2. PubMed ID: 6424257 [No Abstract] [Full Text] [Related]
2. [Acute kidney failure in lead poisoning; the role of EDTA]. Tolot F; Prost G; Neulat G Nouv Presse Med; 1978 Oct; 7(36):3252-3. PubMed ID: 104277 [No Abstract] [Full Text] [Related]
3. [EDTA-chelation treatment]. Collet JT Ned Tijdschr Geneeskd; 1992 Jan; 136(4):191-2. PubMed ID: 1736133 [No Abstract] [Full Text] [Related]
4. EDTA chelation therapy for arteriosclerotic heart disease. Med Lett Drugs Ther; 1981 May; 23(11):51. PubMed ID: 6785565 [No Abstract] [Full Text] [Related]
5. [The risk of EDTA treatment of atherosclerosis]. Hopp F Ugeskr Laeger; 1990 Jun; 152(24):1757. PubMed ID: 2113733 [No Abstract] [Full Text] [Related]
6. [Arteriosclerosis and chelate therapy]. Nissel H Wien Med Wochenschr; 1986 Nov; 136(21-22):586-8. PubMed ID: 3103339 [TBL] [Abstract][Full Text] [Related]
7. [EDTA in treatment of atherosclerosis]. Galløe AM; Galløe M; Lund CM; Graudal N Ugeskr Laeger; 1988 Nov; 150(46):2843-4. PubMed ID: 3144786 [No Abstract] [Full Text] [Related]
8. So much writing, so little science: a review of 37 years of literature on edetate sodium chelation therapy. Grier MT; Meyers DG Ann Pharmacother; 1993 Dec; 27(12):1504-9. PubMed ID: 8305786 [TBL] [Abstract][Full Text] [Related]
9. EDTA chelation therapy for atherosclerotic cardiovascular disease. Med Lett Drugs Ther; 1994 May; 36(923):48. PubMed ID: 8177139 [No Abstract] [Full Text] [Related]
10. [EDTA in the treatment of arteriosclerosis]. Mikaelsen PM Tidsskr Nor Laegeforen; 1995 Apr; 115(11):1392-3. PubMed ID: 7770839 [TBL] [Abstract][Full Text] [Related]
11. [Acute kidney failure following administration of cephalothin and gentamicin: renal histologic examination and optical and electronic microscopy]. Fillastre JP; Laumonier R; Humbert G; Dubois D; Métayer M; Delpech A; Leroy J; Robert M J Urol Nephrol (Paris); 1973; 79(4):383-4. PubMed ID: 4720135 [No Abstract] [Full Text] [Related]
12. Potential nephrotoxicity of intravenous infusions of naftidrofuryl oxalate. Le Meur Y; Moesch C; Rincé M; Aldigier JC; Leroux-Robert C Nephrol Dial Transplant; 1995; 10(9):1751-5. PubMed ID: 8559500 [TBL] [Abstract][Full Text] [Related]
13. Acute alcoholic myopathy, rhabdomyolysis and acute renal failure: a case report. Singh S; Sharma A; Sharma S; Sud A; Wanchu A; Bambery P Neurol India; 2000 Mar; 48(1):84-5. PubMed ID: 10751822 [TBL] [Abstract][Full Text] [Related]
14. Chelation therapy for the treatment of atherosclerosis. An appraisal. Pentel P; Jorgensen C; Somerville J Minn Med; 1984 Feb; 67(2):101-3. PubMed ID: 6425621 [No Abstract] [Full Text] [Related]
15. Nontraumatic rhabdomyolysis and acute renal failure associated with oral phenmetrazine hydrochloride. Black WD; Murphy WM J Tenn Med Assoc; 1984 Feb; 77(2):80-1. PubMed ID: 6727334 [No Abstract] [Full Text] [Related]
16. Final report on the safety assessment of EDTA, calcium disodium EDTA, diammonium EDTA, dipotassium EDTA, disodium EDTA, TEA-EDTA, tetrasodium EDTA, tripotassium EDTA, trisodium EDTA, HEDTA, and trisodium HEDTA. Lanigan RS; Yamarik TA Int J Toxicol; 2002; 21 Suppl 2():95-142. PubMed ID: 12396676 [TBL] [Abstract][Full Text] [Related]
17. Thrombotic microangiopathy and renal failure exacerbated by epsilon-aminocaproic acid. Mutter WP; Stillman IE; Dahl NK Am J Kidney Dis; 2009 Feb; 53(2):346-50. PubMed ID: 18805613 [No Abstract] [Full Text] [Related]